PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
BackgroundLeone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundSHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“For example, pancreatic glucagon induces expression of the gluconeogenic program, through protein kinase A–mediated phosphorylation of the nuclear factor cAMP response element binding protein (CREB”
BackgroundNew Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692 · cited 1×
“Fasting triggers a series of hormonal and nutritional cues that promote energy balance by stimulating glucose output and lipid breakdown in the live”
BackgroundLipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin
Péterfy, M., Phan, J., Xu, P., & Reue, K. (2001) · Nature Genetics · doi:10.1038/83685 · Cited by 604 · cited 1×
“Notably, hepatic TRB-3 is elevated in fatty liver dystrophic mice, which have high levels of circulating lipids and are intolerant to glucose during sucklin”
BackgroundRhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492 · cited 1×
“04 μCi/min) of D -[3- 3 H]glucose (New England Nuclear) into rats fasted for 6 h, as previously describe”
MethodSelf-citationPeroxisome Proliferator-Activated Receptors: From Genes to Physiology
Kliewer, S. A. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.239 · Cited by 425 · cited 1×
“Influx of free fatty acids from adipose tissue stimulates β-oxidation through the nuclear receptor PPAR-&alpha”
BackgroundImai, E., Miner, J. N., Mitchell, J. A., Yamamoto, K. R., & Granner, D. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53327-5 · Cited by 301
Mouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 252
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K., Bernal-Mizrachi, C., Zemany, L., Weng, S., Feng, C., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 229
Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice
Bernal-Mizrachi, C., Weng, S., Feng, C., Finck, B. N., Knutsen, R. H., Leone, T. C., Coleman, T., Mecham, R. P., Kelly, D. P., & Semenkovich, C. F. (2003) · Nature Medicine · doi:10.1038/nm898 · Cited by 212 · cited 1×
“PPAR-α-deficient mice also show increased insulin sensitivity in the context of LDL recepto”
BackgroundIdentification of a subtype selective human PPARα agonist through parallel-array synthesis
Brown, P. J., Stuart, L. W., Hurley, K. P., Lewis, M. C., Winegar, D. A., Wilson, J. G., Wilkison, W. O., Ittoop, O. R., & Willson, T. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00188-3 · Cited by 177
Kruszynska, Y. T., Worrall, D. S., Ofrecio, J. M., Frías, J. P., Macaraeg, G. B., & Olefsky, J. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.226 · Cited by 169
Self-citationThiazolidinedione Treatment Prevents Free Fatty Acid–Induced Insulin Resistance in Male Wistar Rats
Hevener, A. L., Reichart, D., Janez, A., & Olefsky, J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2316 · Cited by 78 · cited 1×
“04 μCi/min) of D -[3- 3 H]glucose (New England Nuclear) into rats fasted for 6 h, as previously describe”
MethodSelf-citationGlucose Regulation of Mouse S14 Gene Expression in Hepatocytes
Koo, S.-H., & Towle, H. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5200 · Cited by 77
Self-citationKlingenspor, M., Xu, P., Cohen, R. D., Welch, C. L., & Reue, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23078 · Cited by 30 · cited 1×
“TRB-3 levels in liver are elevated in the fatty liver dystrophic mous”
Background
Cited by
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
“The PGC-1a RNAi adenovirus was a kind gift from Marc Montminy (Koo et al., 2004), while the PGC-1b RNAi was from Lin et al. (2005b).”
MethodMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
“In fact, acute knockdown of PGC-1α in liver improves hepatic insulin sensitivity and glucose tolerance in db/db mice (Koo et al., 2004).”
BackgroundThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Self-citationInsulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.